We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$155M
AUM Growth
-$13.2M
Cap. Flow
-$5.65M
Cap. Flow %
-3.65%
Top 10 Hldgs %
47.05%
Holding
97
New
21
Increased
19
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$1.82M
2
MCHI icon
iShares MSCI China ETF
MCHI
+$1.58M
3
ET icon
Energy Transfer Partners
ET
+$1.44M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.32M
5
NEM icon
Newmont
NEM
+$934K

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$2.12M
2
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$2.09M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.76M
4
GLD icon
SPDR Gold Trust
GLD
+$1.61M
5
ALT icon
Altimmune
ALT
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 40.07%
2 Technology 13.62%
3 Communication Services 8.36%
4 Financials 5.63%
5 Energy 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$443B
$10.2M 6.6%
76,100
+1,000
+1% +$143K
ARGX icon
2
argenx
ARGX
$53.4B
$8.83M 5.7%
25,000
– –
MU icon
3
Micron Technology
MU
$930B
$8.77M 5.66%
175,000
– –
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.72M 4.99%
165,999
-40,589
-20% -$2.12M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.36T
$7.69M 4.97%
80,000
+3,000
+4% +$335K
REGN icon
6
Regeneron Pharmaceuticals
REGN
$78.5B
$7.61M 4.92%
11,050
-1,650
-13% -$1.04M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$7.32M 4.73%
+20,500
New +$8.14M
XNCR icon
8
Xencor
XNCR
$1.5B
$6.02M 3.89%
231,800
-18,000
-7% -$515K
BAC icon
9
Bank of America
BAC
$435B
$4.53M 2.93%
150,000
+4,500
+3% +$150K
PRTA icon
10
Prothena Corp
PRTA
$425M
$4.12M 2.66%
68,000
+144
+0.2% +$4.55K
ET icon
11
Energy Transfer Partners
ET
$70.1B
$3.97M 2.57%
360,000
+129,100
+56% +$1.44M
AAPL icon
12
Apple
AAPL
$4.54T
$3.77M 2.43%
27,250
-2,000
-7% -$314K
GLD icon
13
SPDR Gold Trust
GLD
$131B
$3.48M 2.25%
22,500
-10,000
-31% -$1.61M
PRTA icon
14
CALL
Prothena Corp
PRTA
$425M
$3.18M 2.06%
+52,500
New +$1.66M
IAU icon
15
iShares Gold Trust
IAU
$62.9B
$3.15M 2.04%
100,000
– –
C icon
16
Citigroup
C
$222B
$3.13M 2.02%
75,000
-5,000
-6% -$247K
T icon
17
AT&T
T
$159B
$2.99M 1.93%
195,000
+100,000
+105% +$1.82M
INCY icon
18
Incyte
INCY
$24.2B
$2.93M 1.89%
44,000
– –
ALT icon
19
Altimmune
ALT
$552M
$2.92M 1.89%
229,000
-106,180
-32% -$1.57M
LLY icon
20
Eli Lilly
LLY
$1.02T
$2.67M 1.72%
8,250
– –
GDX icon
21
VanEck Gold Miners ETF
GDX
$22.7B
$2.47M 1.6%
102,500
-12,500
-11% -$316K
AERI
22
DELISTED
Aerie Pharmaceuticals
AERI
$2.38M 1.54%
157,665
-9,500
-6% -$110K
ORCL icon
23
Oracle
ORCL
$374B
$2.38M 1.54%
39,000
– –
IMPL
24
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$2.29M 1.48%
469,183
+30,617
+7% +$234K
AAPL icon
25
PUT
Apple
AAPL
$4.54T
$2.07M 1.34%
+15,000
New +$2.35M
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, DCF Advisers held 97 positions worth $155M, down 7.8% from $168M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

DCF Advisers withdrew a net $5.65M in Q3 2022, closing 24 positions and reducing 18 holdings. Its most notable exit was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in iShares MSCI China ETF worth $1.36M.

  • DCF Advisers's largest Q3 2022 buy was iShares MSCI China ETF: 32,000 shares worth $1.36M.
  • DCF Advisers added most to AT&T in Q3 2022, an estimated $1.82M increase.
  • DCF Advisers's biggest Q3 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $2.12M.
  • DCF Advisers fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q3 2022, selling an estimated $2.09M.
  • DCF Advisers's ten largest holdings make up 47% of its $155M portfolio in Q3 2022.
  • DCF Advisers opened 21 new positions and closed 24 in Q3 2022.
  • DCF Advisers's portfolio value fell 7.8% quarter-over-quarter to $155M.

Based on DCF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.